COURSE PROGRAM
1
Table of Contents Information and Overview………………………………..…...………2
Faculty Listing……………………………………………..………….3
Agenda ………………………………..………………..…..................4
Course Materials Registered participants can access recorded lectures for on demand viewing
beginning September 28, 2020 via the link below:
https://www.movementdisorders.org/MDS/Education/Workshops-
Conferences/Virtual-Education-Courses/MDS-ES/BASIC20VIRT/Main.htm
Lectures are available on-demand through October 31, 2020 to registered participants.
International Parkinson and Movement
Disorder Society - European Section
International Secretariat 555 East Wells Street, Suite 1100 • Milwaukee, WI 53202 USA
Email: [email protected]
Tel: +1 (414) 276-2145 • Fax: +1 (414) 276-3349
The International Parkinson and Movement Disorder Society (MDS) is an international
professional society of clinicians, scientists, and other healthcare professionals who are interested
in Parkinson’s disease, related neurodegenerative and neurodevelopmental disorders, hyperkinetic
Movement Disorders, and abnormalities in muscle tone and motor control.
2
COURSE DESCRIPTION
The overall aim of the course is to teach the fundamental mechanisms underlying aggregation
and propagation of -synuclein and tau protein in neurodegenerative movement disorders.
Ongoing efforts for the development of therapeutic strategies targeting these two proteins will
also be discussed. The course consists of seven virtual lectures given by international experts in
the field, followed by an interactive Q&A session to answer the questions of the participants.
The course will close with an interactive panel discussion including all experts to address the
critical next steps to move the field forward.
The course is part of a broader effort of the International Parkinson and Movement Disorder
Society to engage young neurologists and neuroscientists into research on movement disorders
and promote translational research involving multidisciplinary approaches.
LEARNING OBJECTIVES
At the conclusion of this activity, you should be able to:
Describe the prototypical neuropathological lesions observed in synucleinopathies and
tauopathies
Recognize the complex mechanisms underlying pathological aggregation of -synuclein
and tau protein
Debate the putative role of distinct -synuclein and tau species/strains for disease
phenotypes and progression
Discuss ongoing efforts towards the development of therapies targeting -synuclein or
tau protein
EDUCATION DISCLAIMER
The primary purpose of MDS programming is to provide educational opportunities that enhance patient
care. Information presented, as well as publications, technologies, products and/or services discussed are
intended to inform attendees about the knowledge, techniques and experiences of physicians who are
willing to share such information with colleagues. A diversity of opinions exists in the medical field, and
the views of the workshop’s faculty are offered solely for educational purposes. Faculty members’ views
do not represent those of the MDS and do not constitute endorsement by MDS.
RECORDINGS PROHIBITED
Audio and videotaping are not allowed during the course. Photography of the presentations and slides is
not allowed during the activity.
COURSE EVALUATIONS
Course evaluations are available online. Please take time to complete the online evaluation form provided
following this course. Your input and comments are essential in planning future educational programs.
INFORMATION AND OVERVIEW
3
COURSE DIRECTORS
Erwan Bezard, PhD
Institute of Neurodegenerative Diseases
(IMN), University Bordeaux
Bordeaux, France
Wassilios Meissner, MD, PhD
Institute of Neurodegenerative Diseases
(IMN), University Bordeaux
Bordeaux, France
COURSE FACULTY
Morvane Colin, PhD
University of Lille
Lille, France
Maria Grazia Spillantini, FRS FMedSci
University of Cambridge
Cambridge, United Kingdom
Gunter Höglinger, MD, PhD Medical School Hannover
Hannover, Germany
Tiago Outeiro, PhD University Medical Center Goettingen
Goettingen, Germany
Laura Parkkinen, PhD
University of Oxford
Oxford, United Kingdom
4
Streaming Schedule
14:00
CEST
Welcome and Course Introduction
Erwan Bezard and Wassilios Meissner
14:05
CEST
Neuropathology in Synucleinopathies and Tauopathies
Laura Parkkinen
14:33
CEST
Mechanisms Underlying Protein Aggregation in Synucleinopathies
Tiago Outeiro
15:05
CEST
Mechanisms Underlying Protein Aggregation in Tauopathies
Maria Grazia Spillantini
15:35
CEST
Propagation of α-synucleinopathy
Erwan Bezard
16:05
CEST
Spreading of Tauopathies
Morvane Colin
16:35
CEST
Therapeutic Strategies Targeting α-synuclein: From Bench to Bed
Wassilios Meissner
17:08
CEST
Therapeutic Strategies Targeting Tau Protein: From Bench to Bed
Günther Höglinger
Live Interaction Schedule
17:40
CEST
Interactive Question and Answer Session
All Faculty – Moderated by
18:05
CEST
Critical Next Steps to Move the Field Forward
Discussion between faculty and participants
18:30
CEST
Concluding Remarks
Erwan Bezard and Wassilios Meissner
ONLINE COURSE AGENDA